These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31441360)

  • 1. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
    Go H; Jang JY; Kim CW; Huh J; Kim PJ; Jeon YK
    Leuk Lymphoma; 2020 Jan; 61(1):66-74. PubMed ID: 31441360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
    Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
    Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S; Wang H; Yang Q; Liu Z; Du J; Wang L; Chen S; Lu Q; Yang DH
    Cancer Lett; 2024 Aug; 597():217058. PubMed ID: 38880226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
    Chen HH; Huang WT; Yang LW; Lin CW
    Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
    Paik JH; Jang JY; Jeon YK; Kim WY; Kim TM; Heo DS; Kim CW
    Clin Cancer Res; 2011 Jul; 17(14):4761-71. PubMed ID: 21610143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.
    Liang L; Nong L; Zhang S; Zhao J; Ti H; Dong Y; Zhang B; Li T
    J Exp Clin Cancer Res; 2014 Jan; 33(1):7. PubMed ID: 24438193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
    Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
    Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
    Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.
    Zhang X; Ji W; Huang R; Li L; Wang X; Li L; Fu X; Sun Z; Li Z; Chen Q; Zhang M
    Oncotarget; 2016 Aug; 7(33):53808-53819. PubMed ID: 27462776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.
    Ng SB; Yan J; Huang G; Selvarajan V; Tay JL; Lin B; Bi C; Tan J; Kwong YL; Shimizu N; Aozasa K; Chng WJ
    Blood; 2011 Nov; 118(18):4919-29. PubMed ID: 21921041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of microRNA in extranodal NK/T cell lymphoma, nasal type].
    Ti HJ; Nong L; Wang W; Zhang S; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):610-5. PubMed ID: 22177245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
    Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
    Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
    Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
    Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.
    Lin TC; Liu TY; Hsu SM; Lin CW
    Am J Pathol; 2013 May; 182(5):1865-75. PubMed ID: 23608226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
    Zhang Y; Li C; Zhang M; Li Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of miR-34a-3p/5p, miR-141-3p/5p, and miR-24 in Decidual Natural Killer Cells with Unexplained Recurrent Spontaneous Abortion.
    Li D; Li J
    Med Sci Monit; 2016 Mar; 22():922-9. PubMed ID: 26996957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.